Touyun Biotech Group (HKSE:01332) Total Inventories : HK$15.3 Mil (As of Jun. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Touyun Biotech Group Total Inventories?

Touyun Biotech Group's total inventories for the quarter that ended in Jun. 2024 was HK$15.3 Mil. Touyun Biotech Group's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Jun. 2024 was HK$15.3 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Touyun Biotech Group's Net-Net Working Capital per share for the quarter that ended in Jun. 2024 was HK$-0.20.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Touyun Biotech Group's Days Inventory for the six months ended in Jun. 2024 was 67.80.

Inventory Turnover measures how fast the company turns over its inventory within a year. Touyun Biotech Group's Inventory Turnover for the quarter that ended in Jun. 2024 was 2.69.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Touyun Biotech Group's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 0.21.

Touyun Biotech Group Total Inventories Historical Data

The historical data trend for Touyun Biotech Group's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Touyun Biotech Group Total Inventories Chart

Touyun Biotech Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Inventories

Get a 7-Day Free Trial

33.74

32.77

35.61

15.25

24.59

Touyun Biotech Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Inventories	Get a 7-Day Free Trial															35.61	33.51	15.25	15.29	24.59

Touyun Biotech Group Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Touyun Biotech Group (HKSE:01332) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Touyun Biotech Group's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2024 is

	Net-Net Working Capital Per Share (Q: Jun. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(13.757	+	0.75 * 31.85	+	0.5 * 15.294	-	597.417
-	0	-	21.071)	/	2805.952
=	-0.20

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Touyun Biotech Group's Days Inventory for the six months ended in Jun. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jun. 2024 )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
	=	15.2715	/	41.108	*	365 / 2
	=	67.80

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Touyun Biotech Group's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jun. 2024 )	/	Average Total Inventories (Q: Jun. 2024 )
	=	41.108	/	15.2715
	=	2.69

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Touyun Biotech Group's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	15.2715	/	74.267
	=	0.21

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Touyun Biotech Group Total Inventories Related Terms

Thank you for viewing the detailed overview of Touyun Biotech Group's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Touyun Biotech Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Touyun Biotech Group Ltd (HKSE:01332) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG

Website

https://www.touyunbiotech.com.hk

Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, an investment holding company, designs, develops, manufactures, and sells packaging products and point-of-sales display units. It operates with four business segments, Packaging Products, Treasury Investment, QR code business, and Chlamydomonas reinhardtii product business. Through the Packaging Products segment, it offers watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units whereas the Treasury segment engages in the trading of securities and money lending activities. It derives a majority of its revenue from the Packaging products. The business activity of the group is operated in Hong Kong, Mainland China, North and South America, and other countries.

Executives

Wang Liang	2101 Beneficial owner
Tian Yuze	2101 Beneficial owner
Tian Yuze	2101 Beneficial owner
Qiao Yanfeng	2201 Interest of corporation controlled by you
Qin Fen	2101 Beneficial owner

Touyun Biotech Group Headlines

No Headlines